TruDoc Healthcare announced that it has acquired Mumbai, India-based Wellthy Therapeutics, Asia’s leading clinically validated chronic disease management platform.
Founded in 2011 in the United Arab Emirates, TruDoc is a telehealth and virtual care provider, including virtual clinics and hospitalist programs for telemonitoring for acute and chronic care. Private equity firm Pulsar Capital acquired a majority stake in TruDoc in September 2023.
The integration of Wellthy Therapeutics’ behavioral science and digital therapeutic solutions with TruDoc’s virtual and in-home healthcare services ensures round-the-clock access to high-quality care, tailored treatment plans and innovative care delivery methods for TruDoc’s patients. The acquisition also expands TruDoc into new markets, including India. Financial terms of the deal were not disclosed.
According to data captured in the LevinPro HC database, this transaction represents the 40th eHealth acquisition of 2024, and the seventh in the telehealth specialty. In 2023, 273 eHealth and 60 telehealth transactions were announced.
